Belgium vs Kuwait: The number of people with susceptibility test result for rifampicin
Belgium
377
in 2021
Kuwait
401
in 2021
Belgium rank
86th
Kuwait rank
85th
The number of people with susceptibility test result for rifampicin over time
- Belgium
- Kuwait
How they compare
Kuwait currently reports 401 against 377 in Belgium, a difference of 24.
That makes Kuwait's figure about 1.1 times Belgium's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Belgium ahead.
Belgium ranks 86th and Kuwait ranks 85th of 155 countries.
Across the 2 decades both report, Belgium averaged higher in 1 and Kuwait in 1.
Head to head by decade
| Decade | Belgium | Kuwait | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 430 | 346.33 | 83.67 | Belgium |
| 2020s | 348.5 | 350 | 1.5 | Kuwait |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Belgium or Kuwait?
- Kuwait, at 401 against 377 in Belgium as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Belgium and Kuwait?
- 24, with Kuwait ahead.
- How many years of comparable data are there for Belgium and Kuwait?
- 5 years are reported by both, from 2017 to 2021.
- How do Belgium and Kuwait rank globally for the number of people with susceptibility test result for rifampicin?
- Belgium ranks 86th and Kuwait ranks 85th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.